ROMMEL AQUINO: Open Payments
NPI 1619906773 · BURTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 68 payments from 16 companies in 2025. Trend: 2023 $1,603 · 2024 $1,634 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $248 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $161 |
| GlaxoSmithKline, LLC. | 3 | $151 |
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| Amgen Inc. | 5 | $85 |
| PFIZER INC. | 3 | $65 |
| Exact Sciences Corporation | 3 | $58 |
| Novo Nordisk Inc | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
Products named: VRAYLAR, XIFAXAN, BREZTRI, AREXVY, OTEZLA, ELIQUIS, The Cologuard Plus Collection Kit, UBRELVY.
Industry payments across MI — which companies pay providers there.
